US Patent Issued to Ohio State Innovation Foundation on March 31 for "Human anti-PD-L1 peptide vaccines and methods of their use" (Ohio Inventor)

ALEXANDRIA, Va., March 31 -- United States Patent no. 12,589,143, issued on March 31, was assigned to Ohio State Innovation Foundation (Columbus, Ohio).

"Human anti-PD-L1 peptide vaccines and methods of their use" was invented by Pravin T.P. Kaumaya (Westerville, Ohio).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are compositions related to synthetic PD-L1 peptides, chimeric PD-L1 peptides, anti-PD-L1 antibodies and methods of treating cancers, autoimmune diseases, and Alzheimer's disease using said peptides or antibodies."

The patent was filed on Sept. 17, 2020, under Application No. 17/761,457.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/...